Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.132 USD | -1.75% | +8.78% | -82.86% |
14/05 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Vivos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-82.86% | 70.03L | |
+75.69% | 1.26TCr | |
+5.42% | 690.22Cr | |
+14.03% | 578.51Cr | |
-16.76% | 486.26Cr | |
+20.13% | 426.5Cr | |
-18.62% | 396.36Cr | |
-23.21% | 286.5Cr | |
+55.46% | 245.57Cr | |
+1.49% | 204.19Cr |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Transcript : Vivos Therapeutics, Inc. - Shareholder/Analyst Call